In a new scientific achievement that reflects the leadership of Helwan University in applied scientific research, a research team from the College of Pharmacy succeeded in registering a US patent number (12258321 B1) on March 25, 2025, as part of the university’s efforts to support innovation and find innovative scientific solutions to confront intractable diseases."RTL"> & nbsp;
The researchers were able to develop a new test of chemical compounds that demonstrated a noticeable effectiveness in stopping the spread of cancer cells, which paves the way for the discovery of a new generation of medicines used in the treatment of tumors. Prof. Dr. Mustafa Al -Arabi, Prof. Yara Mansour, Prof. Dr. Samar Fathallah, Prof. Ahmed Saeed, and Dr. Shahanda Mahjoub from the College of Pharmacy at Helwan University, where their studies contributed to opening new horizons for research in the field of treatments for tumors.
& nbsp;
& nbsp;
& nbsp;
For his part, Dr. Mohamed Ibrahim, Dean of the Faculty of Pharmacy at Helwan University, explained that the recording of the patent is evidence of the efficiency of the college researchers and their ability to develop advanced therapeutic solutions. He stressed that this achievement enhances the position of the College of Pharmacy as one of the leading academic institutions in scientific research, noting that the college is constantly working to support applied research that contributes to developing the health care sector and finding effective solutions to chronic diseases."RTL"> & nbsp;
This achievement comes within the vision of Helwan University to enhance the role of scientific research in achieving sustainable development, and supporting research projects that keep pace with the latest global developments in the medical and scientific fields.
& nbsp;
& nbsp;
& nbsp; In applied scientific research, a research team from the College of Pharmacy succeeded in registering an American patent No. (12258321 B1) on March 25, 2025, as part of the university’s efforts to support innovation and find innovative scientific solutions to counter incurable diseases."RTL"> & nbsp;
The researchers were able to develop a new test of chemical compounds that demonstrated a noticeable effectiveness in stopping the spread of cancer cells, which paves the way for the discovery of a new generation of medicines used in the treatment of tumors. Prof. Dr. Mustafa Al -Arabi, Prof. Yara Mansour, Prof. Dr. Samar Fathallah, Prof. Ahmed Saeed, and Dr. Shahanda Mahjoub from the College of Pharmacy at Helwan University, where their studies contributed to opening new horizons for research in the field of treatments for tumors.
& nbsp;
& nbsp;
& nbsp;
For his part, Dr. Mohamed Ibrahim, Dean of the Faculty of Pharmacy at Helwan University, explained that the recording of the patent is evidence of the efficiency of the college researchers and their ability to develop advanced therapeutic solutions. He stressed that this achievement enhances the position of the College of Pharmacy as one of the leading academic institutions in scientific research, noting that the college is constantly working to support applied research that contributes to developing the health care sector and finding effective solutions to chronic diseases."RTL"> & nbsp;
This achievement comes within the vision of Helwan University to enhance the role of scientific research in achieving sustainable development, and supporting research projects that keep pace with the latest global developments in the medical and scientific fields.
& nbsp;
